Trial intelligence / Profile preview

Effect of glucocorticosteroids on physical performance in COPD with acute inflammatory response after exercise

2012-004503-13Phase 4Completed

Sponsor
Bispebjerg and Frederiksberg Hospital
Start
Jan 2013
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of prednisolone in chronic obstructive pulmonary disease (COPD), sponsored by Bispebjerg and Frederiksberg Hospital. Primary endpoint: Cycling performance improvement with glucocorticoids. Started Jan 2013; status: completed.

02

Drugs

prednisolone
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on 2012-004503-13.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-004503-13.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call